Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. (IDXX) vs Illumina, Inc. (ILMN)

IDEXX Laboratories, Inc. and Illumina, Inc. are both Diagnostics & Research companies. IDEXX Laboratories, Inc. and Illumina, Inc. are of similar size ($41.3B and $40.2B). IDEXX Laboratories, Inc. trades at the lower P/E: 36.2× against 50.4×. IDEXX Laboratories, Inc. grew revenue faster over the last twelve months: 12.8% against 4.88%. IDEXX Laboratories, Inc. has the higher net margin (25.0% vs 18.4%) and the higher return on invested capital (48.9% vs 17.5%). Across the 22 metrics below, IDEXX Laboratories, Inc. leads on 17 and Illumina, Inc. on 5.

Valuation

Metric IDXX ILMN Diagnostics & Research median
P/E 36.24 50.39 33.95
P/S 9.00 9.16 4.87
P/B 25.42 14.50 3.12
Price to free cash flow 33.14 44.94 34.02
EV/EBITDA 25.58 35.99 25.20
EV/Sales 9.06 9.25 5.66
Earnings yield 2.76% 1.98% (1.75%)
Free cash flow yield 3.02% 2.23% (0.13%)

Profitability

Metric IDXX ILMN Diagnostics & Research median
Gross margin 62.45% 66.39% 50.89%
Operating margin 32.03% 19.65% (8.57%)
Net margin 25.03% 18.36% (6.37%)
Free cash flow margin 27.17% 20.72% 0.00%
Return on equity 74.21% 32.38% (2.92%)
Return on assets 33.65% 12.95% (6.71%)
Return on invested capital 48.87% 17.46% 0.00%

Growth

Metric IDXX ILMN Diagnostics & Research median
Revenue growth (TTM) 12.77% 4.88% 7.69%
EPS growth (last fiscal year) 22.59% 170.87% —
Revenue growth, 5-year CAGR 9.72% 6.04% 7.40%
Net income growth, 5-year CAGR 12.74% 5.32% 0.00%

Health

Metric IDXX ILMN Diagnostics & Research median
Debt to equity 0.28 0.53 0.11
Current ratio 1.17 1.80 2.02
Net debt to EBITDA 0.18 (0.13) 0.78

Dividend

Metric IDXX ILMN Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric IDXX ILMN Diagnostics & Research median
Market cap 40.18b 41.25b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack